Pairing liver-driven inflammation with adrenal androgen reserve
The CRP/DHEA‑S ratio is a composite blood marker that compares two signals: C‑reactive protein (CRP) and dehydroepiandrosterone sulfate (DHEA‑S). CRP is an acute‑phase protein made by the liver when inflammatory messengers rise (interleukin‑6 and related cytokines). DHEA‑S is the sulfated, long‑circulating form of the adrenal androgen DHEA, produced in the adrenal cortex (zona reticularis) and acting as a hormone precursor pool that tissues can draw on.
This ratio places the body's inflammatory activity (CRP) in context with its adrenal androgen reserve (DHEA‑S). It reflects the interplay between catabolic immune demands and anabolic/restorative capacity, giving a compact view of immune–endocrine balance. Because CRP can shift rapidly with inflammation while DHEA‑S changes more slowly, the ratio highlights ongoing inflammatory load against a steadier hormonal background. In practical terms, it helps frame how much the system is signaling "defense and breakdown" versus "maintenance and repair," capturing a biologically intuitive balance between the liver‑driven acute‑phase response and adrenal‑derived androgenic support.
Immune load against anabolic capacity
The CRP/DHEA‑S ratio captures the balance between two opposing forces: CRP signals whole‑body inflammation and tissue stress, while DHEA‑S reflects adrenal resilience, repair capacity, and anti‑inflammatory tone. Together, the ratio offers a systems‑level snapshot of immune activation versus anabolic reserve that touches cardiovascular, metabolic, musculoskeletal, and brain health.
This ratio pairs C‑reactive protein, a liver-made acute‑phase marker of systemic inflammation, with DHEA‑S, an adrenal steroid that reflects anabolic reserve and anti‑inflammatory counter‑regulation. Together they index inflammatory load relative to adrenal buffering, which links to energy production, insulin signaling, vascular integrity, tissue repair, immunity, and brain function.
Lower, mid, and higher ratios across the lifespan
There is no single universal cut‑off because CRP is normally very low and DHEA‑S varies with age and sex. In general, a lower‑to‑mid ratio is considered favorable, indicating quiet inflammation with age‑appropriate DHEA‑S.
When the ratio is low, it usually means minimal inflammatory activity or relatively higher DHEA‑S. People often feel well. If driven by excess DHEA‑S, effects can include oily skin, acne, or unwanted hair growth and irregular cycles in women, and may reflect androgen excess states. Teens naturally have higher DHEA‑S after adrenarche, so a low ratio can be normal for age.
Low values usually reflect low inflammation and/or higher adrenal reserve. In plain terms, the immune system is quiet and the body has more "brakes" on inflammation. This tends to align with stable endothelial function, better metabolic flexibility, and efficient recovery. Very low ratios can also arise from unusually high androgens (e.g., androgen excess in women) or, rarely, from abnormally low CRP production in severe liver dysfunction or profound immunosuppression.
Being in range suggests balanced inflammatory tone with adequate adrenal support, a pattern seen in cardiometabolic and cognitive resilience. In many healthy adults, ratios trend toward the lower half of the reference interval. Because DHEA‑S declines with age and is higher in men than women, age‑ and sex‑specific ranges matter.
When the ratio is high, it reflects increased CRP and/or low DHEA‑S. This pattern aligns with fatigue, poor stress tolerance, achiness, brain fog, and slower recovery. Organ‑system effects include endothelial dysfunction, insulin resistance, loss of muscle and bone (sarcopenia/osteopenia), and mood changes. The ratio tends to rise with aging as DHEA‑S declines; it can spike with infections or autoimmune flares. In pregnancy, CRP may be modestly higher while DHEA‑S drops, pushing the ratio upward.
High values usually reflect higher CRP and/or lower DHEA‑S, indicating active inflammatory signaling with reduced counter‑regulation. Systems-level effects include more catabolic drive, endothelial activation, insulin resistance, sarcopenia, and higher atherosclerotic risk. Ratios often run higher in older adults and postmenopausal women. Acute infection, autoimmune activity, and adiposity raise CRP. Pregnancy typically lowers DHEA‑S and modestly raises CRP, increasing the ratio physiologically.
Estrogen, illness timing, and assay choice
Interpretation depends on both components and on age‑ and sex‑specific DHEA‑S ranges. Use high‑sensitivity CRP for chronic risk. DHEA‑S is stable diurnally; CRP changes with illness. Oral estrogens tend to raise CRP and lower DHEA‑S, increasing the ratio. Assay methods and acute illness can shift values.
Defense-and-breakdown versus repair, on one axis
This ratio integrates immune load with adrenal‑anabolic capacity. Interpreted alongside the individual CRP and DHEA‑S values (and age, sex, and pregnancy status), it links to cardiometabolic risk, resilience, and long‑term vitality.
FAQs
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., Rifai, N., Smith, S. C., Taubert, K., Tracy, R. P., & Vinicor, F. (2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107(3), 499-511. https://doi.org/10.1161/01.cir.0000052939.59093.45
- Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576-590. https://doi.org/10.1038/s41574-018-0059-4
- Dharia, S., & Parker, C. R. (2004). Adrenal androgens and aging. Seminars in Reproductive Medicine, 22(4), 361-368. https://doi.org/10.1055/s-2004-861552
- Erceg, N., Micic, M., Forouzan, E., & Knezevic, N. N. (2025). The role of cortisol and dehydroepiandrosterone in obesity, pain, and aging. Diseases, 13(2), 42. https://doi.org/10.3390/diseases13020042
- Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., & Torpy, D. J. (2016). Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 101(2), 364-389. https://doi.org/10.1210/jc.2015-1710






































.avif)
